OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial
Yi Ji, Siyuan Chen, Jiangyuan Zhou, et al.
Blood (2022) Vol. 139, Iss. 11, pp. 1619-1630
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Long‐term outcomes of sirolimus treatment for kaposiform hemangioendothelioma: Continuing successes and ongoing challenges
Jiangyuan Zhou, Yanan Li, Tong Qiu, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 3, pp. 600-608
Closed Access | Times Cited: 14

Consensus statement for the diagnosis, treatment, and prognosis of kaposiform hemangioendothelioma
Jiangyuan Zhou, Tong Qiu, Zixin Zhang, et al.
International Journal of Cancer (2025)
Closed Access

Successful use of oral sirolimus – A mammalian target of rapamycin (m-TOR) inhibitor in the treatment of kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon
Shekhar Neema, Senkadhir Vendhan, Biju Vasudevan, et al.
Indian Journal of Dermatology Venereology and Leprology (2025), pp. 1-3
Open Access

Clinical features and current management experience in Gorham-Stout disease: a systematic review
Zilong Zhou, Tong Qiu, Jiangyuan Zhou, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access

Sirolimus treatment for intractable vascular anomalies (SIVA): An open‐label, single‐arm, multicenter, prospective trial
Michio Ozeki, Saori Endo, Shiho Yasue, et al.
Pediatrics International (2025) Vol. 67, Iss. 1
Open Access

Challenges and treatment outcome of patients with Kaposiform hemangioendothelioma: a retrospective single center experience
Nihal Hussien Aly, Amr Abdelhamid AbouZeid, Shaimaa Abdelsattar Mohammad, et al.
Egyptian Pediatric Association Gazette (2025) Vol. 73, Iss. 1
Closed Access

Hypoxia-driven angiogenesis and metabolic reprogramming in vascular tumors
Lu Liu, Jiayun Yu, Yang Liu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access

Treatment practices and response in kaposiform hemangioendothelioma: A multicenter cohort study
Alexandra J. Borst, Whitney Eng, Morgan Griffin, et al.
Pediatric Blood & Cancer (2023) Vol. 71, Iss. 3
Open Access | Times Cited: 9

Euphorbia helioscopia L. exhibits promising therapeutic effects on hemangioendothelioma and melanoma through angiogenesis inhibition
Man Dou, Dongliang Zhu, Guozhen Cui, et al.
Phytomedicine (2024) Vol. 129, pp. 155666-155666
Closed Access | Times Cited: 3

Incidence, demographics, and survival of malignant hemangioendothelioma in the United States
Kelly G. Paulson, Vinod Ravi, Brian P. Rubin, et al.
Cancer Medicine (2023) Vol. 12, Iss. 14, pp. 15101-15106
Open Access | Times Cited: 8

Infectious complications of vascular anomalies treated with sirolimus: A systematic review
Rachel Kalbfell, Sally Cohen‐Cutler, Eric Grisham, et al.
Pediatric Blood & Cancer (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 7

Indications and Limitations of Sirolimus in the Treatment of Vascular Anomalies—Insights From a Retrospective Case Series
Anna Karastaneva, Paolo Gasparella, Sebastian Tschauner, et al.
Frontiers in Pediatrics (2022) Vol. 10
Open Access | Times Cited: 11

Uracil-Cu(i) catalyst: allylation of cyclopropanols with Morita–Baylis–Hillman alcohols under water-tolerant conditions
Jingwei Hou, Xiaohong Li, Kaiyu Yan, et al.
Chemical Science (2023) Vol. 15, Iss. 3, pp. 1143-1149
Open Access | Times Cited: 6

Construction and applications of the EOMA spheroid model of Kaposiform hemangioendothelioma
Yanan Li, Xinglong Zhu, Li Li, et al.
Journal of Biological Engineering (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2

Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases
Xue Gong, Min Yang, Zixin Zhang, et al.
Hepatology International (2024)
Closed Access | Times Cited: 2

Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus
Zuopeng Wang, Hanlei Yan, Yangyang Ma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 5

Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study
Tong Qiu, Yanan Li, Xue Gong, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4

Kaposiform hemangioendothelioma complicated by Kasabach–Merritt phenomenon in an infant girl
Louise Helligsø, Torben Stamm Mikkelsen, Anne‐Mette Hvas
Clinical Case Reports (2023) Vol. 11, Iss. 9
Open Access | Times Cited: 4

Case Report: Tuberous sclerosis complex-associated hemihypertrophy successfully treated with mTOR inhibitor sirolimus
Konomi Shimoda, Hiroyuki Iwasaki, Yoko Mizuno, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1

Fucoidan suppresses proliferation and epithelial‐mesenchymal transition process via Wnt/β‐catenin signalling in hemangioma
Zhengyumeng Zhu, Jialiang Luo, Lei Li, et al.
Experimental Dermatology (2024) Vol. 33, Iss. 3
Closed Access | Times Cited: 1

Coexistence of kaposiform hemangioendothelioma and capillary malformation: More than a coincidence? Two case reports
Xue Gong, Jiangyuan Zhou, Siyuan Chen, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28802-e28802
Open Access | Times Cited: 1

Page 1 - Next Page

Scroll to top